JP2024532372A5 - - Google Patents
Info
- Publication number
- JP2024532372A5 JP2024532372A5 JP2024513158A JP2024513158A JP2024532372A5 JP 2024532372 A5 JP2024532372 A5 JP 2024532372A5 JP 2024513158 A JP2024513158 A JP 2024513158A JP 2024513158 A JP2024513158 A JP 2024513158A JP 2024532372 A5 JP2024532372 A5 JP 2024532372A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- antibody
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163237663P | 2021-08-27 | 2021-08-27 | |
| US63/237,663 | 2021-08-27 | ||
| US202163277245P | 2021-11-09 | 2021-11-09 | |
| US63/277,245 | 2021-11-09 | ||
| US202263339784P | 2022-05-09 | 2022-05-09 | |
| US63/339,784 | 2022-05-09 | ||
| PCT/IB2022/057979 WO2023026236A1 (en) | 2021-08-27 | 2022-08-25 | Anti-psma radioconjugates and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532372A JP2024532372A (ja) | 2024-09-05 |
| JP2024532372A5 true JP2024532372A5 (https=) | 2025-09-01 |
Family
ID=85322811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513158A Pending JP2024532372A (ja) | 2021-08-27 | 2022-08-25 | 抗ｐｓｍａ放射性コンジュゲート及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230122503A1 (https=) |
| EP (1) | EP4392081A4 (https=) |
| JP (1) | JP2024532372A (https=) |
| KR (1) | KR20240053607A (https=) |
| AU (1) | AU2022335002A1 (https=) |
| CA (1) | CA3230156A1 (https=) |
| MX (1) | MX2024002479A (https=) |
| TW (1) | TW202327660A (https=) |
| UY (1) | UY39912A (https=) |
| WO (1) | WO2023026236A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10806806B2 (en) | 2016-06-23 | 2020-10-20 | Cornell University | Trifunctional constructs with tunable pharmacokinetics useful in imaging and anti-tumor therapies |
| CN109843339B (zh) | 2016-06-23 | 2023-07-07 | 康奈尔大学 | 影响肿瘤杀伤的双重靶向构建体 |
| JP7699542B2 (ja) | 2018-11-20 | 2025-06-27 | コーネル ユニバーシティー | 放射線核種の大環状錯体およびがんの放射線療法におけるそれらの使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5355839B2 (ja) * | 2001-10-23 | 2013-11-27 | ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． | Ｐｓｍａ抗体およびタンパク質マルチマー |
| CA2742969A1 (en) * | 2008-11-07 | 2010-05-14 | Fabrus Llc | Anti-dll4 antibodies and uses thereof |
| CA2880791A1 (en) * | 2011-08-03 | 2013-02-07 | Children's Medical Center Corporation | A broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza hemagglutinin |
| US10844111B2 (en) * | 2015-05-06 | 2020-11-24 | Janssen Biotech, Inc. | Prostate specific membrane antigen binding fibronectin type III domains |
| IL269763B2 (en) * | 2017-03-30 | 2024-08-01 | Univ Cornell | Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer |
| JP7699542B2 (ja) * | 2018-11-20 | 2025-06-27 | コーネル ユニバーシティー | 放射線核種の大環状錯体およびがんの放射線療法におけるそれらの使用 |
| BR112021022237A2 (pt) * | 2019-05-10 | 2022-03-29 | Janssen Biotech Inc | Queladores macrocíclicos e métodos de uso dos mesmos |
| UY39510A (es) * | 2020-11-10 | 2022-05-31 | Janssen Biotech Inc | Compuestos macrocíclicos y métodos para usarlos |
| EP4284838A2 (en) * | 2021-01-28 | 2023-12-06 | Janssen Biotech, Inc. | Psma binding proteins and uses thereof |
-
2022
- 2022-08-25 KR KR1020247009635A patent/KR20240053607A/ko active Pending
- 2022-08-25 AU AU2022335002A patent/AU2022335002A1/en active Pending
- 2022-08-25 CA CA3230156A patent/CA3230156A1/en active Pending
- 2022-08-25 EP EP22860757.8A patent/EP4392081A4/en active Pending
- 2022-08-25 MX MX2024002479A patent/MX2024002479A/es unknown
- 2022-08-25 JP JP2024513158A patent/JP2024532372A/ja active Pending
- 2022-08-25 WO PCT/IB2022/057979 patent/WO2023026236A1/en not_active Ceased
- 2022-08-25 TW TW111132107A patent/TW202327660A/zh unknown
- 2022-08-25 US US17/895,312 patent/US20230122503A1/en active Pending
- 2022-08-26 UY UY0001039912A patent/UY39912A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024532372A5 (https=) | ||
| JP2024119791A5 (https=) | ||
| JP2024535712A5 (https=) | ||
| JP2020534351A5 (https=) | ||
| JP2021526512A5 (https=) | ||
| JP2022542450A5 (https=) | ||
| JP2021534797A5 (https=) | ||
| JP7645799B2 (ja) | ヘテロダイマー抗体の作製方法 | |
| JP2023528350A5 (https=) | ||
| JP7597784B2 (ja) | 胸腺間質性リンパ球新生因子（ｔｓｌｐ）受容体シグナル伝達に干渉する薬剤 | |
| JP2023522730A5 (https=) | ||
| AU2014248636B2 (en) | Humanized anti-N2 antibodies | |
| JP2020518248A5 (https=) | ||
| WO2019195126A1 (en) | Anti-trem-1 antibodies and uses thereof | |
| JP2024540148A5 (https=) | ||
| US10640576B2 (en) | Cell engaging binding molecules | |
| JP2021525059A5 (https=) | ||
| JP2024534034A5 (https=) | ||
| CA3074317C (en) | Fc.gamma.rii binding fibronectin type iii domains, their conjugates and multispecific molecules comprising them | |
| JP2024502863A5 (https=) | ||
| JP2024523514A5 (https=) | ||
| RU2024107310A (ru) | Радиоконъюгаты к psma и способы их применения | |
| JP2023523794A (ja) | 人工操作免疫グロブリン | |
| NZ769634B2 (en) | Anti-sirpa antibodies and methods of use thereof | |
| NZ769634A (en) | Anti-sirpa antibodies and methods of use thereof |